Abstract
The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | National Cancer Institute. Journal (Print) |
| Vol/bind | 102 |
| Udgave nummer | 5 |
| Sider (fra-til) | 325-39 |
| Antal sider | 15 |
| ISSN | 0027-8874 |
| DOI | |
| Status | Udgivet - 3 mar. 2010 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS